In today’s unpredictable global trade environment, with rising tariffs and tensions, investors are looking for stability.

You could earn truly passive income with these investments. Find out how much you'll make in a single year, depending on how ...

Gilead Sciences has agreed to pay $202 million to resolve allegations that it violated the Anti-Kickback Statute by using speaker programs to incentivize physicians to prescribe HIV medications.

Gilead will pay $202 million to resolve claims that it paid kickbacks to healthcare providers in the form of honoraria, meals ...

Dozens of trials on HIV ground to a halt in February after US President Donald Trump abruptly pulled crucial funding.